M&A / Deals Gilead inks $140M API supply deal, tightening ties to Korean manufacturer BioSpaceThe agreement is the largest in a series of deals that Gilead Sciences has penned with Korea's Yuhan.Read full story pharminent May 22, 2026 (Last updated: May 22, 2026) BioSpace The agreement is the largest in a series of deals that Gilead Sciences has penned with Korea’s Yuhan. Read full story Post navigation Previous: GBL joins CVC in 10.7bn takeover bid for RecordatiNext: Kelun-Merck validate TROP2-Keytruda pairing in lung cancer with improved survival Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
